Cargando…
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
BACKGROUND: Chemotherapy resistance remains a barrier to improving the prognosis of epithelial ovarian cancer (EOC). ALKBH5 has recently been shown to be one of the RNA N6-methyladenosine (m6A) demethyltransferases associated with various cancers, but its role in cancer therapeutic resistance remain...
Autores principales: | Nie, Sipei, Zhang, Lin, Liu, Jinhui, Wan, Yicong, Jiang, Yi, Yang, Jing, Sun, Rui, Ma, Xiaolling, Sun, Guodong, Meng, Huangyang, Xu, Mengting, Cheng, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425158/ https://www.ncbi.nlm.nih.gov/pubmed/34496932 http://dx.doi.org/10.1186/s13046-021-02088-1 |
Ejemplares similares
-
ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer
por: Sun, Rui, et al.
Publicado: (2023) -
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2021) -
Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6
por: Gong, Mi, et al.
Publicado: (2019) -
MicroRNA-665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10
por: Liu, Jinhui, et al.
Publicado: (2018) -
ALKBH4-dependent demethylation of actin regulates actomyosin dynamics
por: Li, Ming-Ming, et al.
Publicado: (2013)